Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05846646
Title Study of PULSAR-ICI +/- IMSA101 in Patients With Oligometastatic NSCLC and RCC
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors ImmuneSensor Therapeutics Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
City of Hope Orange County Lennar Foundation Cancer Center Irvine California 92618 United States Details
The University of Kansas Medical Center Kansas City Kansas 66160 United States Details
Rutgers Cancer Institute of New Jersey New Brunswick New Jersey 08903 United States Details
Laura & Isaac Perlmutter Cancer Center at NYU Langone Health New York New York 10016 United States Details
Louis Stokes Cleveland VA Medical Center Cleveland Ohio 44106 United States Details
MetroHealth Medical Center Cleveland Ohio 44109 United States Details
Baylor College of Medicine Medical Center Houston Texas 77030 United States Details
Huntsman Cancer Institute, University of Utah Salt Lake City Utah 84112 United States Details
University of Wisconsin Hospital and Clinics Madison Wisconsin 53792 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field